Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Beneficial Effect of Tolerogenic Dendritic Cells Pulsed with MOG Autoantigen in Experimental Autoimmune Encephalomyelitis.
Cost Effectiveness Analysis of Avonex and CinnoVex in Relapsing Remitting MS.
Neuropsychiatric disorders among Syrian and Iraqi refugees in Jordan: a retrospective cohort study 2012-2013.
Sphingosine 1-phosphate signaling at the blood-brain barrier.
Disability progression in relapsing MS is more than just lesions: The lesson of fingolimod.
Targeting endothelial CD146 attenuates neuroinflammation by limiting lymphocyte extravasation to the CNS.
Apoptosis of oligodendrocytes in the central nervous system results in rapid focal demyelination.
Protective effect of cytosolic phospholipase A2 inhibition against inflammation and degeneration by promoting regulatory T cells in rats with experimental autoimmune encephalomyelitis.
Myelin Oligodendrocyte Glycoprotein (MOG35-55) Induced Experimental Autoimmune Encephalomyelitis (EAE) in C57BL/6 Mice.
Merck Loses Protection for Patent on Zocor
Quantitative analysis of the suppressors of cytokine signaling 1 and 3 in peripheral blood leukocytes of patients with multiple sclerosis.
Treatment-related progressive multifocal leukoencephalopathy: current understanding and future steps.
Autoantibodies and Sjogren's Syndrome in Multiple Sclerosis, a Reappraisal.
Examining the factor structure of the multiple sclerosis impact scale.
Clinical and MRI activity as determinants of sample size for pediatric multiple sclerosis trials.
Exercise therapy and multiple sclerosis: a systematic review.
Serum levels of brain-derived neurotrophic factor (BNDF) in multiple sclerosis patients with Trichuris suis ova therapy.
Inhibition of the immunoproteasome ameliorates experimental autoimmune encephalomyelitis.
Evaluating sex hormone levels in reproductive age women with multiple sclerosis and their relationship with disease severity.
Remote control-triggering of brain autoimmune disease in the gut.
Optical tomographic imaging of near infrared imaging agents quantifies disease severity and immunomodulation of experimental autoimmune encephalomyelitis in vivo.
Detection of postural sway abnormalities by wireless inertial sensors in minimally disabled patients with multiple sclerosis: a case-control study.
Agent based modeling of the effects of potential treatments over the blood-brain barrier in multiple sclerosis.
Distal acquired demyelinating symmetric neuropathy associated with colorectal adenocarcinoma: Should it be termed paraneoplastic?
Integrin-linked kinase regulates oligodendrocyte cytoskeleton, growth cone, and adhesion dynamics.
Pages
« first
‹ previous
…
479
480
481
482
483
484
485
486
487
…
next ›
last »